Latest Strategic Partnerships News

Airtasker Limited reports a strong HY26 with positive operating cash flow and robust international revenue growth, led by explosive gains in the US and UK marketplaces.

Smartgroup Corporation Ltd reported robust 2025 results, driven by digital innovation, expanding customer base, and a strengthened sustainability strategy. The company declared generous dividends and outlined a confident outlook for continued margin expansion.

Riversgold has dramatically expanded its Kalgoorlie Gold Project tenements by over 800%, positioning itself for long-term development with a new mining agreement that shares funding and profits with MEGA Resources.

Tungsten Mining is pursuing a US stock exchange listing to tap into deeper capital markets and strengthen ties with US government and industry stakeholders, complementing its existing ASX listing.

Alcidion Group Limited has reported a robust half-year performance with a 44% revenue increase and a return to profitability, driven by key contract expansions and new wins in the UK and Australia. The company is now positioned to secure a major Electronic Patient Record contract with University Hospitals Sussex NHS Foundation Trust.

NeuroScientific Biopharmaceuticals reported a $1.7 million loss for the half-year ending December 2025, driven by ongoing R&D investments. The company progressed clinical treatments for Crohn’s disease and glaucoma, alongside key leadership appointments and strategic partnerships.

Cleo Diagnostics reported a 53% drop in revenues and a slight increase in net loss to $1.98 million for H1 2025, while progressing its pivotal FDA clinical trial for an ovarian cancer blood test with strong regulatory and commercial milestones.

Global Health Limited reports a modest half-year loss reduction alongside a steady rise in recurring SaaS revenue, signaling progress in its digital healthcare transformation.

HITIQ Limited reported a $2.9 million loss for the half-year ending December 2025, while making significant strides in international market expansion and strategic partnerships. The company’s capital raising efforts aim to support its transition from technology validation to commercial execution.

Caravel Minerals confirms its Definitive Feasibility Study for the Caravel Copper Project remains on track for mid-2026, while regulatory water investigations push the Final Investment Decision to late 2027. Meanwhile, strategic talks with Adani advance steadily.

Pharmx Technologies reported a 3.1% revenue increase to $3.89 million for H1 FY26 but posted a net loss of $512,000 driven by strategic investments. The company also announced a significant multi-year alliance with Sigma Healthcare.

Riversgold has completed a significant drilling campaign at its Northern Zone within the Kalgoorlie Gold Project, with mining lease approval expected imminently. Collaborative efforts with MEGA Resources are accelerating plans for gold extraction in 2026.